鼻塞式持续气道正压通气联合小剂量多巴胺治疗重症毛细支气管炎患儿的价值探讨.doc

鼻塞式持续气道正压通气联合小剂量多巴胺治疗重症毛细支气管炎患儿的价值探讨
[摘要] 目的 分析鼻塞式持續气道正压通气联合小剂量多巴胺治疗重症毛细支气管炎的价值。 方法 在2018年1—12月方便选取该院接受诊疗的重症毛细支气管炎作为案he routine group was % and %, respectively. The clinical effective rate of the experimental group was significantly higher than that of the routine group, and there was statistically significant difference between the two groups(χ2=, P<). In the experimental group, the respiration returned to normal, the heart rate returned to normal, cough disappeared, wheezing disappeared, rale disappeared (±)d, (±)d, (±)d, (±)d, (±)d. In the routine group, the respiration returned to normal, the heart returned to normal, cough disappeared, wheezing disappeared, rale disappeared (±)d,(±)d,(±)d,(±)d,(±)d,The disappearance time of symptoms in the experimental group was significantly shorter than that in the routine group, and there was statistically significant difference between the two groups (t=, , , , , P<). The incidence of complications in the experimental group and the routine group was % and %, respectively. It was significantly lower than that in the routine group, and there was statistically significant difference between the two groups(χ2=, P<). Conclusion Nasal continuous positive airway pressure ventilation combined with low dose dopamine is of great value in the treatment of severe bronchiolitis. It can relieve the clinical symptoms of children in time and effectively. The overall treatment is safe and worthy of popularization and application. [Key words] Nasal continuous positive airway pressure ventilation; Low dose dopamine; Severe bronchiolitis; Clinical value
重症毛细支气管炎属于一种比较普遍的呼吸道感染性疾病,临床症状以气喘、咳嗽、喘憋、三凹征阳性以及肺部喘鸣等为主,一般发生在2~6个月的婴儿中[1]。临床有许多研究都发现,毛细支气管炎的患儿年龄越小,疾病的发生与发展速度会越快,并且发生心力衰竭、呼吸衰竭的风险会更高,所以年龄较小的患儿死亡风险也比较高[2]。近些年有许多关于重症毛细支气管炎的治疗研究,其中有部分是关于鼻塞式持续气道正压通气的治疗研究,研究中认为该治疗方式能够有效改善供氧质量,优化呼吸功能,从而实现生活质量的